Blockbuster Management

Previous Page 1 of 4 Next >

Search returned 32 items.

sort by: Title | Author | Publication | Date

Drug research: To test or to tout?

In the 1990s, drug companies trumpeted a new class of drugs, atypical antipsychotics,

Date: 04/12/2008 , Publication: St. Pete Times , Author: Robert Farley

http://www.tampabay.com/news/health/article454391.ece

Risks of Anemia Drugs for Patients With Cancer to Get More Scrutiny

But in 1990 Dr. Anagnostou published some of the first evidence suggesting that Amgen&8217;s then brand-new anemia drug, Epogen, might fuel the growth of tumors. Few people paid heed.

Date: 03/12/2008 , Publication: NY TIMES , Author: ANDREW POLLACK

http://www.nytimes.com/2008/03/12/business/12anemia.html?ref=health

Tomorrow's Drugs

Seven top therapies and technologies vying to deliver the next decade's breakthroughs and blockbusters. They want to become...

Date: 07/30/2007 , Publication: Pharmaceutical Executive , Author: The Staff of Pharmaceutical Executive

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=446938

Marketing to Professionals: The Advertorial Effect

A study suggests that advertorials are powerful marketing tools before and after a drug is approved

Date: 06/01/2007 , Publication: Pharmaceutical Executive , Author: Gwen Canter, Johanna Schlossberg

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=429157

Leadership: Outsmarting Your Competitors

Gaining market share isn't something you do only oncethink of it as running a race with no finish line

Date: 06/01/2007 , Publication: Pharmaceutical Executive , Author: Sander Flaum

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=429151

The Best-Sellers List

The 2007 Sales and Marketing Quality Ranking scores the most effective sales forces in the industry.

Date: 03/01/2007 , Publication: Pharmaceutical Executive , Author: Mike Luby, Patrick Howie

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=410701

Introduction: Branded for Life

Coke or Pepsi. Mac or PC. Developing brand loyalty takes time and patience, but the payoff is worth it in the end.

Date: 03/01/2007 , Publication: Pharmaceutical Executive , Author: Jeannette Park

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=408168

Direct to Consumer: Q&A with Mark Spellman and Loreen Babcock

Operation Fear Factor

Date: 03/01/2007 , Publication: Pharmaceutical Executive , Author: Mark Spellman

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=408476

Awakening a Sleepy Market

... the tried-and-true blockbuster model is not dead just yet. want proof? Have a look at the insomnia market.

Date: 01/01/2007 , Publication: Pharmaceutical Executive , Author: Fred Nelson

http://www.pharmexec.com/pharmexec/article/articleDetail.jsp?id=395595

Beyond Blockbusters

While not a panacea, pharmacogenomics is still a valuable trial tool.

Date: 01/01/2007 , Publication: Applied Clinical Trials , Author: Michael Murphy

http://www.actmagazine.com/appliedclinicaltrials/article/articleDetail.jsp?id=3

Previous Page 1 of 4 Next >

Search returned 32 items.